The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product (BP) must be authorised before it can be made available on the market or used in the European Union (EU)/ European Economic Area (EEA).
This takes place in two consecutive steps. As the first step, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type (PT). The second step is the authorisation of each BP consisting of, containing or generating the approved active substance(s).
This document concerns the first step, approval of active substances.
October 2016
Collegati
Arsenic, metals, fibres, and dusts
Volume 100 of the IARC Monographs, A Review of Human Carcinogens, covers all agents previously classified by IARC as "carcinogenic to humans (Grou...
ID 20895 | 05.12.2023 / In allegato
Proposta di regolamento di modifica Regolamento (UE) 2019/1021 (Regolamento POP...
ID 12414 | Update 23.02.2021
Regolamento delegato (UE) 2021/277
Pubblicato nella GU L 62/1 del 23.2.2021 il Regolamento delegat...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024
